Please use this identifier to cite or link to this item: http://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13893
Full metadata record
DC FieldValueLanguage
dc.contributor.authorVasyuk, V.L.-
dc.contributor.authorIlashchuk, T.O.-
dc.date.accessioned2018-06-13T08:52:34Z-
dc.date.available2018-06-13T08:52:34Z-
dc.date.issued2015-
dc.identifier.otherУДК 616.361-089:570.8-002:615.24-
dc.identifier.urihttp://dspace.bsmu.edu.ua:8080/xmlui/handle/123456789/13893-
dc.description.abstractAim of investigation is to determine the liver condition of rats with experimental immunodeficiency. Immune deficiency (ID) in rats was induced by the injection of the cytostatic cyclophosphamide. The presence of ID was determined by lymphocytes levels (in the blood) and lysocyme (in the serum and liver). The presence of hepatitis was identified by the levels of biochemical markers of liver inflammation (MDA, elastase) and cholestasis (ALP) as well as by the level of "liver markers" (ALT, bilirubin, alkaline phosphatase - ALP) in serum. Cyclophosphamide reduces the lymphocyte and lysocyme levels, and increases hepatic levels of inflammatory markers and cholestasis, and serum levels of "liver markers". Cyclophosphamide causes the development of immunodeficiency and hepatitis.ru_RU
dc.language.isoenru_RU
dc.publisherКлінічна та експериментальна патологіяru_RU
dc.subjectimmunodeficiencyru_RU
dc.subjectliverru_RU
dc.subjecthepatitisru_RU
dc.subjectenzymesru_RU
dc.subjectімунодефіцитru_RU
dc.subjectпечінкаru_RU
dc.subjectгепатитru_RU
dc.subjectферментиru_RU
dc.subjectиммунодефицитru_RU
dc.subjectпеченьru_RU
dc.subjectгепатитru_RU
dc.subjectферментыru_RU
dc.titleCondition of rat' liver with experimental immunodeficiencyru_RU
dc.typeArticleru_RU
Appears in Collections:Статті. Кафедра пропедевтики внутрішніх хвороб

Files in This Item:
File Description SizeFormat 
16.pdf219.62 kBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.